October 20, 2016 by Chain Drug Review
AmerisourceBergen, Express Scripts, Prime Therapeutics, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Leading Headlines, Retail News
DEERFIELD, Ill. — As talks roll on to gain regulatory clearance for its acquisition of Rite Aid Corp., Walgreens Boots Alliance (WBA) posted adjusted earnings for its fiscal 2016 fourth quarter and full year that beat Wall Street’s estimates. WBA said Thursday that GAAP net earnings attributable to Walgreens Boots Alliance totaled $1.03 billion, or
October 19, 2016 by Chain Drug Review
Get a Shot. Give a Shot, Kathy Calvin, Ornella Barra, UN Foundation, United Nations Foundation 2016 Global Leadership Award, Walgreens, Walgreens Boots Alliance, WBA
Retail News
NEW YORK — Walgreens Boots Alliance (WBA) is receiving a United Nations Foundation 2016 Global Leadership Award for its “Get a Shot. Give a Shot.” vaccination campaign. WBA said co-chief operating officer Ornella Barra will accept the award on behalf of the company tonight at the UN Foundation Global Leadership Awards Dinner in New York.
October 10, 2016 by Geoff Walden and Chain Drug Review
CVS, Federal Trade Commission, FTC, Kroger, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA, WBA-Rite Aid
2016, Issue 10-10-2016, Issues, News
NEW YORK — Speculation continues to percolate about snags holding up Walgreens Boots Alliance Inc.’s (WBA’s) acquisition of Rite Aid Corp. Last last month the New York Post reported that private equity firms were uninterested in purchasing 650 stores that WBA must divest to satisfy antitrust requirements. Investors found the stores to be subpar and
September 29, 2016 by CDR Blog and Chain Drug Review
chain drug industry, CVS, Federal Trade Commission, Kroger, Rite Aid, Scott Mushkin, Walgreens Boots Alliance, Walmart, WBA, Wolfe Research
CDR Blog
It looks like one divestment possibility for Walgreens Boots Alliance isn’t panning out as it works with the Federal Trade Commission to gain antitrust clearance for its acquisition of Rite Aid. The New York Post reported this week that WBA hasn’t been able to sway private equity firms to buy a chunk of Walgreens and/or
September 7, 2016 by CDR Blog and Chain Drug Review
Albertsons, Kroger, Rite Aid, Sareway Haggen, Walgreens, Walgreens Boots Alliance, WBA
CDR Blog, Leading Headlines
The suspense (or impatience?) continues to build in the investor and retailing communities as Walgreens Boots Alliance’s $17.2 billion deal to buy Rite Aid remains under review by the Federal Trade Commission. Lately, speculation has centered on Kroger as a potential buyer of stores that would be divested by WBA for the FTC to sign
August 29, 2016 by Chain Drug Review
Alex Gourlay, Jim DuCharme, PBM, pharmacy benefit management, Prime Therapeutics, specialty pharmacy, Walgreens, Walgreens Boots Alliance, WBA
Featured Articles, Leading Headlines, Pharmacy, Retail News
DEERFIELD, Ill., and ST. PAUL, Minn. — Walgreens has entered into a long-term alliance with Prime Therapeutics, the nation’s fourth-largest pharmacy benefit manager, that will include the creation of a joint pharmacy services company. Under the partnership, Walgreens and Prime will combine their central specialty pharmacy and mail service businesses, the companies said Monday. The
August 6, 2016 by Greg Jacobson and Chain Drug Review
Boots, Emart, Gab-Soo Lee, hypermarket, Ornella Barra, Shinsegae Group, Walgreens Boots Alliance, WBA
2016, Issue 08-08-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) has signed an agreement to form a franchise partnership with Emart Co., a subsidiary of South Korea’s largest retailer, Shinsegae Group. Under the terms of the partnership, the two companies will create a pharmacy-led health and beauty retail franchise in South Korea operating under the Boots banner.
August 6, 2016 by Jeffrey Woldt and Chain Drug Review
Ahold, Delhaize, Federal Trade Commission, Jeffrey Woldt, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, Walgreens-Rite Aid merger, WBA
2016, Featured Articles, Issue 08-08-2016, Issues, Leading Headlines, Opinion
It has been slightly more than nine months since Walgreens Boots Alliance agreed to acquire Rite Aid in a $17.2 billion all-cash transaction. Since that time, speculation about whether the Walgreens-Rite Aid merger will pass muster with the Federal Trade Commission has become a staple of discussion for people involved in community pharmacy and the
July 25, 2016 by Brian Bossetta
Alex Gourlay, National Institutes of Health, PMI Cohort Program, USA Precision Medicine Initiative, Walgreens, Walgreens Boots Alliance, WBA
2016, Issue 07-25-2016, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) is participating in the USA Precision Medicine Initiative (PMI) Cohort Program. WBA said its participation is the result of a $20 million grant awarded to The Scripps Research Institute by the National Institutes of Health (NIH). Walgreens will help support patient enrollment and participation in the cohort
July 8, 2016 by CDR Blog
Alex Gourlay, J. Michael Pearson, Joseph Papa, Valeant Pharmaceuticals International, Walgreens Boots Alliance, WBA
CDR Blog
During the Walgreens Boots Alliance’s conference call this week on its third-quarter results, co-COO Alex Gourlay told analysts that WBA will address Valeant Pharmaceuticals International’s concerns about its distribution arrangement with the company. Under the deal, announced in December, WBA and Valeant entered agreements in which the drug maker will directly distribute branded prescription drugs
July 6, 2016 by CDR Blog
Rite Aid, Stefano Pessina, Walgreens Boots Alliance, WBA
CDR Blog, Leading Headlines
Stefano Pessina said Walgreens Boots Alliance remains in the ballpark in terms of likely store divestitures that the Federal Trade Commission will require for WBA to finalize its deal to acquire Rite Aid Corp. “We still believe that our initial estimate is correct. We still believe that at the end we will stay in the
July 6, 2016 by Chain Drug Review
Alliance Boots, AmerisourceBergen, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Featured Articles, Leading Headlines, Retail News
DEERFIELD, Ill. — Walgreens Boots Alliance (WBA) saw sales and adjusted net earnings rise in its fiscal 2016 third quarter, with adjusted earnings per share exceeding Wall Street’s consensus forecast. WBA said Wednesday that its pending acquisition of Rite Aid Corp. remains on track for completion in the second half of this year, and it
June 20, 2016 by Geoff Walden and Chain Drug Review
Alex Gourlay, Boots, Elizabeth Fagan, Kathleen Wilson-Thompson, Ken Murphy, Ornella Barra, Richard Ashworth, Rite Aid, Simon Roberts, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
2016, Issue 06-20-2016, Issues, News
DEERFIELD, Ill. — Alex Gourlay and Ornella Barra have been named co-chief operating officers of Walgreens Boots Alliance Inc. (WBA). Gourlay had been president of Walgreens, and Barra president and chief executive of global wholesale and international retail. Both had also been executive vice presidents of WBA. In his new role, Gourlay will oversee Walgreens
June 20, 2016 by Jeffrey Woldt and Chain Drug Review
Alex Gourlay, AmerisourceBergen, Boots, Jeffrey Woldt, Ornella Barra, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
2016, Featured Articles, Issue 06-20-2016, Issues, Leading Headlines, Opinion
The appointment of Alex Gourlay and Ornella Barra as co-chief operating officers of Walgreens Boots Alliance signals the start of a new stage in the process of forging the two companies that came together to form WBA at the close of 2014 into a new corporate culture. The two executives, whose talent, experience and leadership